Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer

• Yohei Saito,
• Atsushi Mizokami,
• Sayaka Maeda,
• Kyoko Takahashi,
• Kouji Izumi,
• Masuo Goto,
• Kyoko Nakagawa-Goto

Affiliations

Yohei Saito

School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan

Atsushi Mizokami

Department of Integrative Cancer Therapy and Urology, School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Sayaka Maeda

School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan

Kyoko Takahashi

School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan

Kouji Izumi

Department of Integrative Cancer Therapy and Urology, School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Masuo Goto

Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States

Kyoko Nakagawa-Goto

School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa, Japan